Findings from Published Abstracts Showcase the Importance of Nicotinamide Adenine Dinucleotide (NAD+) in Glaucoma Patients and that Supplementation with Nicotinamide Riboside (NR) Demonstrate Promising Effects

Abstracts recently published in the Association for Research in Vision and Ophthalmology (ARVO) journal showcase NR, one of the most efficient and well-researched NAD+ precursors, prevented the worsening of visual field sensitivity in glaucoma patients, and builds on research demonstrating decreased cellular NAD+ levels and impaired mitochondrial function are associated with Primary open-angle glaucoma (POAG)

Related Keywords

London ,City Of ,United Kingdom ,Moorfields ,Ballymena ,Hong Kong ,Andrew Shao ,Davidf Garway Heath ,Christopher Leung ,Department Of Ophthalmology ,Nasdaq ,School Of Clinical Medicine ,Global Scientific Regulatory Affairs ,Association For Research ,Institute Of Ophthalmology ,Chromadex Corp ,Investigative Ophthalmology ,Visual Science ,Clinical Medicine ,Moorfields Eye Hospital ,Progressing Glaucoma ,Parallel Group ,Placebo Controlled Trial ,Chromadex Senior Vice President ,Global Scientific ,Looking Statements ,Securities Act ,Exchange Act ,Annual Report ,Quarterly Reports ,Markets ,